Target intelligence / Profile preview

ZNF230 divergent transcript (ZNF230-DT)

Target
ZNF230-DT
Molecular classification
Other (long non-coding RNA; lncRNA)
01

Overview

ZNF230 divergent transcript (ZNF230-DT) is a non-coding RNA gene found on human chromosome 19 (chr19:43996896-44003298, hg38)[5]. It is classified as a long non-coding RNA (lncRNA), meaning it does not code for a protein product. The exact biological function of ZNF230-DT is currently not established or characterized in the scientific literature, and there are no documented roles in diseases, nor are there associated drugs, mechanisms of action, biomarker status, or safety concerns[3][5]. It is distinctly different from the protein-coding ZNF230 gene (zinc finger protein 230), with no clear evidence indicating ZNF230-DT is a therapeutic target or is implicated in any molecular family such as receptors, enzymes, ion channels, or transporters based on available data[3][5][7]. If additional or structured information is sought in the future, refer to comprehensive genome and transcript databases, but as of now ZNF230 divergent transcript should be understood only as a long non-coding RNA without established biological or therapeutic targeting relevance.

Other names
ZNF230-DTZNF230 divergent transcript
02

Biological functions

Unknown (not established in current literature)
03

Disease associations

Unknown (not established in current literature)

Beyond the preview

Go deeper on ZNF230 divergent transcript (ZNF230-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF230 divergent transcript (ZNF230-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call